grant

Elucidating competence and fate choice dynamics during retinal development

Organization UNIVERSITY OF COLORADO DENVERLocation Aurora, UNITED STATESPosted 1 Sept 2025Deadline 31 Aug 2027
NIHUS FederalResearch GrantFY2025Basal Transcription FactorBasal transcription factor genesBlindnessBody TissuesCell BodyCell Communication and SignalingCell SignalingCell TherapyCell to Cell Communication and SignalingCell-Cell SignalingCellsCompetenceComplexCone PhotoreceptorsDataDecision MakingDegenerative DisorderDevelopmentDiminished VisionDissectionDoseDrosophilaDrosophila genusElectroporationEngineeringEnhancer ElementsEnhancersEquilibriumEventGeneral Transcription Factor GeneGeneral Transcription FactorsGenesGeneticGenetic Enhancer ElementGenetic TechnicsGenetic TechniquesGenomic approachGliaGlial CellsHistologicHistologicallyHybridsIntracellular Communication and SignalingIntrinsic factorKnowledgeKolliker's reticulumLow VisionMiceMice MammalsModelingMultipotent Stem CellsMurineMusNatural regenerationNatureNerve CellsNerve UnitNeural CellNeurocyteNeurogliaNeuroglial CellsNeuronsNon-neuronal cellNonneuronal cellNotch Signaling PathwayOutcomePartial SightPathway interactionsPatternPersonsPhenotypePhotoreceptor CellPhotoreceptorsPhotosensitive CellPlayProbabilityProcessProteolysis and Signaling Pathway of NotchReduced VisionRegenerationRepressionRetinaRetinal ConeRetinal DegenerationRodRods and ConesRoleSightSignal PathwaySignal TransductionSignal Transduction SystemsSignalingSpecific qualifier valueSpecifiedSubnormal VisionSystemTestingTherapeuticTimeTissuesTranscription Factor Proto-OncogeneTranscription factor genesVertebrate PhotoreceptorsVisionVisual ReceptorVisual impairmentWorkbalancebalance functionbiological signal transductioncell based interventioncell fate specificationcell mediated interventioncell mediated therapiescell typecell-based therapeuticcell-based therapycellular therapeuticcellular therapycone celldegenerative conditiondegenerative diseasedegenerative retina diseasesdevelopmentaldosageelectroporative deliveryenhancer sequenceexperimentexperimental researchexperimental studyexperimentsfruit flygain of functiongangliocyteganglion cellgene electrotransfergene regulatory networkgenetic enhancer sequencegenomic effortgenomic strategyhuman progenitorhuman stem cellsintercellular communicationloss of functionmultipotencymultipotentmultipotent progenitormultipotent progenitor cellnerve cell deathnerve cell lossnerve cementneuron cell deathneuron cell lossneuron deathneuron lossneuron regenerationneuronalneuronal cell deathneuronal cell lossneuronal deathneuronal lossneuronal regenerationnotchnotch proteinnotch receptorsnovelpathwaypostmitoticprogenitorprogenitor cell poolprogenitor cell populationprogenitor poolprogenitor populationregenerateregenerativeregenerative approachregenerative strategyregenerative techniquerestore sightrestore visionretina degenerationretina transplantationretinal degenerativeretinal degenerative diseasesretinal neuronretinal progenitorretinal progenitor cellretinal stem cellretinal transplantationretinogenesisscRNA sequencingscRNA-seqsight restorationsingle cell RNA-seqsingle cell RNAseqsingle cell expression profilingsingle cell transcriptomic profilingsingle-cell RNA sequencingsocial rolespatial and temporalspatial temporalspatiotemporalstem and progenitor cell populationstem cell poolstem cell populationtooltranscription factorvision impairmentvision lossvision restorationvisual functionvisual lossvisually impaired
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

PROJECT SUMMARY
Degenerative diseases that cause retinal neuronal cell death often result in permanent vision loss. This is

because retinal neurons, like rod and cone photoreceptors, do not regenerate. The most promising potential

therapeutic strategies for restoring lost vision include artificially stimulating endogenous neuronal regeneration

or programming human stem cells into transplantable retinal tissue. However, realizing such strategies is

hindered by our limited understanding of the developmental mechanisms used to build the retina.

During retinal development, proliferative multipotent progenitor cells choose between seven major fate

outcomes. This choice process, called fate specification, is determined by a combination of a cell’s potential (i.e.,

competence) and instructive factors that select between competing fate choices. Retinal fate specification is a

dynamic, probabilistic process that is controlled by the intersection of intrinsic gene regulatory networks and

environmental cell-cell signaling mechanisms. The Notch signaling pathway impacts competence and fate choice

decisions in the retina. However, its mechanisms are poorly understood due to a lack of genetic tools that can

dynamically manipulate signaling in specific subpopulations of competent cells over time. To overcome this

barrier, we identified enhancer sequences for the key transcription factor Otx2 that drive discrete spatial and

temporal activity patterns in the mouse retina. Using these narrowly tailored enhancer tools, our initial findings

show that Notch signaling plays multiple discrete fate choice roles throughout development. Our objective is to

finely dissect how Notch signaling functions to understand the probabilistic nature of retinal cell fate specification.

In Aim 1 of this proposal, we will investigate how Notch signaling regulates multiple different fate decisions

throughout retinal development. We will activate Notch signaling at discrete stages of retinal development and

use single cell RNA sequencing and histological approaches to determine how cells change competence and

fate choices over time. These data will be used to determine whether Notch signaling delays decision making or

acts by specifically instructing fate choices in competent cells at different stages of development. In Aim 2, we

will use developmental and genetic techniques to explore how Notch signaling exposure (dosage and duration)

differentially impacts competence and retinal cell fate decisions.

Leveraging our unique genetic tools, this project will reveal how the multifaceted Notch signaling pathway

impacts competence and dynamic fate choice probabilities in the developing retina. This knowledge is essential

for creating regenerative and cell-based therapies to replace lost neurons, which may restore vision in millions

of people suffering from retinal degenerative diseases.

Grant Number: 1R21EY037026-01A1
NIH Institute/Center: NIH

Principal Investigator: Joseph Brzezinski

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →